Business News LIVE Today: Latest Business News, Share Market News, Economy & Finance News | Moneycontrol

0



Glenmark Pharma gets approval from Health Canada for nasal spray Ryaltris Health Canada granted approval to partner Bausch Health Companies Inc and Glenmark Specialty SA, a subsidiary of the company, for Ryaltris (olopatadine hydrochloride and mometasone furoate nasal spray), Glenmark Pharmaceuticals said in a statement.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here